4. Drug, bio-affecting and body treating compositions
  5. Designated organic active ingredient containing
  6. Peptide containing doai

Jean-Francois Hernandez

Inventor

Rate now
  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Inventor

active

CRF analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

CRF analogs

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Corticotropin ; related peptides
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

CRF antagonists

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Corticotropin ; related peptides
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

CRF antagonists

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Corticotropin ; related peptides
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

No associations

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Jean-Francois Hernandez does not yet have a rating. At this time, there are no reviews or comments for this inventor.

If you have personal experience with Jean-Francois Hernandez, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Jean-Francois Hernandez will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-P-1139566

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.

Canada

 Charities
 Companies
 MP Candidates
 Patents
 Employee Salary Disclosure

World

 Places of the World
 Scientific Papers

United States

 Banks
 Companies
 Counties
 Patents
 Employee Salary Disclosure